CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 1.851
AS - Asia 1.229
EU - Europa 970
SA - Sud America 170
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 27
OC - Oceania 2
Totale 4.292
Nazione #
US - Stati Uniti d'America 1.783
SG - Singapore 489
IT - Italia 374
CN - Cina 286
BR - Brasile 144
DE - Germania 141
BD - Bangladesh 133
FI - Finlandia 117
HK - Hong Kong 111
VN - Vietnam 64
GB - Regno Unito 55
FR - Francia 54
UA - Ucraina 54
RU - Federazione Russa 42
CA - Canada 39
IN - India 36
TR - Turchia 32
NL - Olanda 29
PL - Polonia 26
IE - Irlanda 24
MX - Messico 14
JP - Giappone 11
AR - Argentina 10
ZA - Sudafrica 10
BE - Belgio 8
ES - Italia 8
PK - Pakistan 8
SE - Svezia 8
AT - Austria 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
TW - Taiwan 6
IR - Iran 5
VE - Venezuela 5
JO - Giordania 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
ID - Indonesia 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
MA - Marocco 3
NP - Nepal 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
KZ - Kazakistan 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
SV - El Salvador 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.250
Città #
Singapore 299
Ashburn 254
Fairfield 128
San Jose 121
Hong Kong 111
Helsinki 94
New York 74
Milan 67
Woodbridge 65
The Dalles 64
Beijing 61
Houston 60
Los Angeles 59
Seattle 52
Wilmington 51
Munich 47
Brescia 45
Cambridge 45
Council Bluffs 44
Jacksonville 44
Ann Arbor 40
Chandler 36
Dallas 29
Lauterbourg 29
Istanbul 25
Dublin 24
Nanjing 24
Princeton 24
Warsaw 24
Ho Chi Minh City 23
Santa Clara 22
Chicago 21
Columbus 20
Turku 20
Buffalo 18
Montreal 17
Dearborn 16
Denver 16
São Paulo 16
Redondo Beach 15
Rome 15
Orem 14
Frankfurt am Main 13
Hanoi 13
San Francisco 13
Des Moines 12
Moscow 12
Mumbai 11
Shanghai 11
Nuremberg 10
Chennai 9
London 9
Jinan 8
Naples 8
Toronto 8
Bologna 7
Brussels 7
Guangzhou 7
Phoenix 7
Stockholm 7
Tokyo 7
Verona 7
Amsterdam 6
Charlotte 6
Düsseldorf 6
Mexico City 6
Monza 6
Poplar 6
Washington 6
Boardman 5
Boston 5
Brasília 5
Castelli Calepio 5
Changsha 5
Da Nang 5
Elk Grove Village 5
Hangzhou 5
Johannesburg 5
Nanchang 5
Ningbo 5
Rio de Janeiro 5
Riyadh 5
Salò 5
San Giuliano Terme 5
Taipei 5
Amman 4
Ardabil 4
Atlanta 4
Bolingbrook 4
Chapel Hill 4
Figino 4
Florence 4
João Pessoa 4
Kunming 4
Norwalk 4
Palermo 4
Philadelphia 4
San Diego 4
Turin 4
Venezia 4
Totale 2.641
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 358
COVID-19 impact on consecutive neurological patients admitted to the emergency department 266
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 240
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 226
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 224
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 186
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 184
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 178
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 167
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 147
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 140
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 129
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 120
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 111
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 100
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 99
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 99
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 98
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 98
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 97
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison 92
Cerebral Amyloid Angiopathy in Alzheimer Disease: A Comparison between Different Versions of the Boston Criteria 92
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 92
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 91
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 89
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 88
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease 82
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 77
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology 72
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 68
Photophobia and migraine outcome during treatment with galcanezumab 62
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 60
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 60
Totale 4.292
Categoria #
all - tutte 18.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 21 1 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025799 16 5 3 141 65 57 67 51 100 72 126 96
2025/20262.093 155 190 119 235 193 195 346 122 132 170 102 134
2026/2027157 93 64 0 0 0 0 0 0 0 0 0 0
Totale 4.292